What is Lung Stereotactic
Ablative Radiosurgery?

Lung Stereotactic Ablative Radiosurgery (SABR) is a non-invasive, highly targeted form of radiation treatment that is recommended in international cancer guidelines as an alternative to surgery in early stage lung cancers for selected patient groups. SABR has been proven in studies to confer excellent survival rates comparable to surgery and is an increasingly important option in early stage lung cancer treatment. 
* The NCCN guidelines on NSCLC is written by 30 leading cancer centres in the U.S and is regarded as the gold standard internationally

Lung SABR is also commonly used in stage 4 cancers to target tumors that have spread to the lung, and to prevent or relief symptoms. Often, it is combined with immunotherapy to achieve a synergistic effect. Unlike surgery or other invasive procedures, SABR does not cause disruption to the continued use of chemotherapy or targeted therapy in these patients.

SABR works by using technologically advanced machines to deliver extremely focused beams carrying high doses of radiation directly to the tumour to destroy it.  With SABR, an entire treatment course can be completed in three to five outpatient sessions over two weeks, with no surgical or anaesthetic risk.

Modern Linear Accelerator with 6 degrees of freedom robotic couch.

Lung SABR destroys lung cancer with painless and precise radiation beams

Understanding the difference between Surgery and Radiosurgery

Modern Linear Accelerator with 6 degrees of freedom robotic couch.

Using advanced technology, radiosurgery precisely targets tumors painlessly, without the need for open surgery